Basic Information
Acclinate, Inc. is a developer of a digital health platform aimed at increasing the representation and diversity of its genomic research and clinical trials. The company's platform uses machine learning and predictive analytics to automate the identification, education, engagement, and retention of willing and diverse participants for genomic research and clinical trials, enabling biopharmaceutical research organizations to reduce the overall cost of drug development.
Acclinate, Inc.
Alabama,United States of America
15~50 people
February 01, 2020
info@acclinate.com

